Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Colorcon
Medtronic
Harvard Business School
Boehringer Ingelheim

Last Updated: August 13, 2022

PROSCAR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Proscar patents expire, and what generic alternatives are available?

Proscar is a drug marketed by Organon and is included in one NDA.

The generic ingredient in PROSCAR is finasteride. There are fourteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the finasteride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Proscar

A generic version of PROSCAR was approved as finasteride by DR REDDYS LABS INC on July 28th, 2006.

  Try it Free

Summary for PROSCAR
Drug patent expirations by year for PROSCAR
Drug Prices for PROSCAR

See drug prices for PROSCAR

Recent Clinical Trials for PROSCAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Baylor College of MedicinePhase 3
Medical Research Collaborating Center, Seoul, KoreaPhase 4
Astellas Pharma Korea, Inc.Phase 4

See all PROSCAR clinical trials

US Patents and Regulatory Information for PROSCAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PROSCAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 See Plans and Pricing See Plans and Pricing
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 See Plans and Pricing See Plans and Pricing
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 See Plans and Pricing See Plans and Pricing
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 See Plans and Pricing See Plans and Pricing
Organon PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PROSCAR

See the table below for patents covering PROSCAR around the world.

Country Patent Number Title Estimated Expiration
Czech Republic 9501268 See Plans and Pricing
Hungary 210535 See Plans and Pricing
Denmark 92192 See Plans and Pricing
Israel 107574 Process for producing finasteride See Plans and Pricing
Czech Republic 9301933 See Plans and Pricing
Greece 940300045 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for PROSCAR

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0155096 SPC/GB93/006 United Kingdom See Plans and Pricing SPC/GB93/006:, EXPIRES: 20070526
0155096 93C0055 Belgium See Plans and Pricing PRODUCT NAME: FINASTERIDUM; NAT. REG..: 922 IS 151 F 3 19930125; FIRST REG.: GB PL 0025/0279 19920527
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
AstraZeneca
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.